DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Travatan Z (Travoprost Ophthalmic) - Current Clinical Trials

 
 



Travatan Z Related Clinical Trials

A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution [Terminated]

Effects of Travatan Z and Xalatan on Ocular Surface Health [Completed]

6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Completed]

Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health [Completed]

Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]

Study of TRAVATAN in Subjects With Iris Pigmentation Changes [Terminated]

Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG) [Terminated]

Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension [Completed]

Travoprost 3-Month Safety and Efficacy Study [Completed]

Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]

Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN [Completed]

Efficacy of Changing to TRAVATAN® From Prior Therapy [Completed]

Divided Dose of TRAVATAN® [Completed]

A Long-term Safety Study of Once-daily Travatan [Completed]

Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004% [Withdrawn]

Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) [Completed]

Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-Weeks, Masked Evaluator, Phase IV Multi-Center Study in the US [Completed]

Efficacy of Changing to TRAVATAN® From Prior Therapy [Completed]

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension [Completed]

A Parallel-Arm, Randomized, Dose-Ranging Study of ENV515 Travoprost Extended-Release (XR) in Subjects With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma [Recruiting]

A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Completed]

Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost [Completed]

The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye [Active, not recruiting]

Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® [Completed]

An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN® [Completed]

Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma [Completed]

Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension [Terminated]

Efficacy Study of Travoprost APS Versus TRAVATAN [Completed]

Effect of Selective Laser Trabeculoplasty Versus Travoprost on Circardian Intraocular Pressure [Recruiting]

Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma [Recruiting]

An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension [Completed]

Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease [Completed]

Effects of Anti-Glaucoma Medications on the Ocular Surface [Recruiting]

Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients [Completed]

Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma [Not yet recruiting]

Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension [Active, not recruiting]

Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension [Completed]

Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R� or Travatan Z� [Completed]

Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension [Completed]

24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost [Completed]

Travoprost Five Day Posology Study [Completed]

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT [Terminated]

Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination Therapy [Completed]

AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure [Completed]

Safety and Efficacy of Travoprost/Timolol BAC-free [Completed]

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [Completed]

Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction [Completed]

A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]

A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension [Completed]

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan [Completed]

Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers [Completed]

A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) [Completed]

Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients [Completed]

24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG [Completed]

Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]

Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy [Completed]

Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]

Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG) [Completed]

Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% [Completed]

Effects of Travoprost on Neovascular Glaucoma [Withdrawn]

Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy [Terminated]

Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative [Completed]

24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol [Completed]

Bimatoprost Versus Travoprost at Cairo University [Completed]

Adherence Assessment With Travalert Dosing Aid [Completed]

IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost [Active, not recruiting]

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost [Recruiting]

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days [Completed]

Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG [Completed]

Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG) [Completed]

24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension [Completed]

Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health [Completed]

How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used? [Completed]

Results of Mass Switch From Latanoprost to Travoprost [Completed]

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Completed]

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004% [Completed]

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma [Completed]

Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure [Completed]

Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension [Completed]

Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension [Completed]

Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension [Completed]

Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues [Completed]

Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes [Completed]

Bimatoprost/Timolol Versus Travoprost/Timolol [Completed]

Value of an Intervention to Enhance Adherence in Glaucoma Patients [Completed]

1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT [Terminated]

Assessing Ocular Surface Changes After Changing Glaucoma Medications [Completed]

24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination [Completed]

Stop Retinal Ganglion Cell Dysfunction Study [Recruiting]

Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients [Completed]

Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect [Completed]

Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav [Completed]

Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia [Withdrawn]

Travacom Post Marketing Surveillance Study [Withdrawn]

Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol [Completed]

Efficacy of Changing to DUOTRAV® From Prior Therapy [Completed]

IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy [Completed]

Global DuoTrav® Study [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017